Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

ANIXANIX
Showing 8 of 23 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in ANIXA BIOSCIENCES INC

CITADEL ADVISORS LLC holds 31,887 shares of ANIX (ANIXA BIOSCIENCES INC), worth $89,284 as of 2026-Q2. This is a new position.

Current Value

$89,284

Current Shares

31,887

Total Value Change

+$71,376

Total Shares Change

+26,202

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
31,887
-
$89,2840.0%$2.80
33
2026-Q1
Exited
0
-100.0%
$00.0%$2.83
0
2025-Q4
Decreased
29,692
-69.1%
$92,6390.0%$3.12
0
2025-Q3
Increased
96,010
+35.3%
$316,8330.0%$3.41
21
2025-Q2
New
70,938
-
$234,0950.0%$3.22
35
2025-Q1
Exited
0
-100.0%
$00.0%$2.97
0
2024-Q4
Increased
87,919
+1446.5%
$203,9720.0%$2.50
25
2024-Q3
New
5,685
-
$17,9080.0%$3.19
28

Other major holders of ANIX: VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used